Hospital financial analysis and third party reimbursementFederal & State Mandatory survey/reporting (DSH Survey, JAR)Gross and net revenue compilation (contractual allowance/deduction modeling)Reimbursement Analytics

Managed the workflow, training, and productivity of 5+ FTE’s Serve as the 340B contract pharmacy subject matter expert, providing account management for MacroHelix (data files for Accredo, OptumRx, ESI, and US Bio), WellPartner, 340B Complete, for All 4 DSH at Memorial Hermann. 340B ESP upload de-identified 340B claims data that originates from contract pharmacies to identify duplicate discounts. Responsible for providing finance based analytical support to all levels of management. Assists in the documentation or analysis of simple financial analysis projects.Collaborate with IT to ensure accuracy of FTP files for each TPA, update 340B Location List, and Provider Files for each covered entity. Monitor, report, and analyze contract pharmacy 340B activities; provide financial reports to 10 hospitals relative to financial impact and liabilities; make recommendations that would improve efficiencyCreate metrics/dashboards/reports to monitor program performance and provide program updates to senior leadership. Assist in the review & updates of the 340B policies and performed a crosswalk on HRSA's recommendations. Communicates with vendor as it relates to contract pharmacy operation.Conduct internal 340B Audits to ensure 340B be compliance and report any findings to the 340B Manager to resolve.Successfully assisted and completed a 340B HRSA Regulatory Audit in collaboration with Compliance, IT, Executives, and Pharmacy team members (February 2022)

Assist in the review & updates of the 340B policies and performed a crosswalk on HRSA's recommendations. Assist developing (2) new 340B policies (Governance Committee & Disaster Policy).Leads the WAC Reduction project and works closely with the Inventory Supervisors to implement processes that will result in reduction. Continually reviews current processes, recognizes potential opportunities, and offers constructive and creative ideas for improvement.Responsible for ensuring charges are reflected accurately in the inpatient and outpatient setting (ongoing)Responsible for developing quarterly business review reports regarding inpatient and outpatient pharmaceutical purchases and charges for all 3 major hospitals (ongoing)Collaborated with Compliance and Patient Financial Services to optimize departmental workflows, standardization of policies and procedures to ensure compliance with business rules externally with vendors/manufacturers of pharmaceuticals and internally (May 2016)Successfully assisted and completed a 340B HRSA Regulatory Audit in collaboration with Compliance, IT, Executives, and Pharmacy team members (February 2016)Successfully implemented inventory software with Epic Inpatient; estimated cost-savings with software that help in saving the hospital system millions of dollars annually (May 2015)Leading efforts to analyze a cost impact report for covered outpatient drugs in the 340B Drug Pricing Program for the Senior Vice President (2019)Communicates with departmental stakeholders to answer or research any 340B related questions.Conduct internal 340B Audits to ensure 340B be compliance and any findings to the 340B Committee to resolve and implement CAP. Responsible planning, reporting, preparation, allocation, distribution for the influenza season,Collaborate with medical director, pharmacy director, and inventory management to ensure retrieval and distribution of the flu vaccine for the system is successful. (2017-2019)

Work with Inventory, Pharmacy IT and Pharmacy Operations teams to leverage 340B software-related cost savings and ensure an ongoing compliance with HRSA regulations Successfully assisted and completed a 340B HRSA Regulatory Audit in collaboration with Compliance, IT, Executives, and Pharmacy team members (February 2016)Successfully implemented inventory software with Epic Inpatient; estimated cost-savings with software is $150M+ annually (May 2015)